Hyogo Medical University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Nishinomiya Japan (1972)

Organization Overview

First Clinical Trial
2001
NCT00152217
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Cardiovascular Division, Hyogo College of Medicine | Chikara Tashiro | Department of Upper Gastrointestinal Surgery, Hyogo College of Medicine | Hyogo College of Medicine | Hyogo College of Medicine, Department of Surgery | Hyogo prefectural Amagasaki Hospital | Hyogo Prefectural AWAJI Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Heart Failure (Phase 4)

Muscular Dystrophies (Phase 2)

Muscular Dystrophy, Duchenne (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms, Second Primary (Phase 2)

Sepsis (Phase 4)

Stomach Neoplasms (Phase 3)

Toxemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 16